News & Views
Collaboration to Deepen Understanding of Molecular Complexes
Jun 27 2016 Read 837 Times
Thermo Fisher Scientific and the National Institute for Bioprocessing Research and Training (NIBRT) have formed a collaboration focused on the development of analytical solutions for the characterisation of complex biopharmaceuticals.
Biopharmaceuticals represent protein molecules produced by genetically engineered living cells using large scale industrial bioprocessing and advanced analytical characterisation is required for the end product to maintain high quality levels. NIBRT will
Under the agreement NIBRT will develop workflows using Thermo Scientific technology including the company’s biomolecule columns and associated consumables, liquid chromatography systems and Orbitrap high resolution mass spectrometers.
“This collaboration is important because it enables our team to access Thermo Fisher’s world leading columns and analytical instrumentation to develop total analytical solutions and streamline the characterisation of complex biopharmaceuticals,” said Dr. Jonathan Bones, principal investigator, NIBRT’s Characterisation and Compatibility Laboratory. “The availability of total analytical solutions to scientists across the world is empowering and motivates us at NIBRT to continually perform excellent impactful research.”
Jakob Gudbrand, president of chromatography and analytical technologies at Thermo Fisher commented: “NIBRT is an independent centre of excellence with collaborations across the major biopharmaceutical companies in the industry. This allows them to provide valuable insights to improve the technology, simplify analysis, generate informative characterisation data and understand these complex molecules -- ultimately enabling scientists to move from sample to knowledge quickly and efficiently.”
NIBRT’s workflows and methods will be uploaded to the Thermo Scientific AppsLab library, enabling scientists across the globe to access and download these total analytical solutions directly to their instrument.
“We are delighted to be working with Thermo Fisher,” said Dominic Carolan, CEO, NIBRT. “World class collaborations such as this are testament to Ireland’s emergence as a global centre of excellence in all aspects of biopharmaceutical manufacturing.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Chromatography - Measurement of Pesticides in Cannabis sativa and Hemp Matrices - Biphenyl Modified Silica Stabilised by Bulky Substituents - Wettable Phase for Analytical a...
View all digital editions
Aug 13 2020 Shanghai, China
Aug 16 2020 San Francisco, CA, USA
Aug 19 2020 Mumbai, India
Aug 19 2020 Mumbai, India
Aug 30 2020 Nantes, France